ChemLifeIntel/Companies/Unexo Life Sciences Private Limited

Unexo Life Sciences Private Limited

HIGH RISKHQ: — · Private · Founded —

LISTINGPrivateFOUNDED0

FOCUS THERAPY AREAS

Manufacturer

COMPANY INTELLIGENCE SNAPSHOTlive

Manufacturing Sites

Intelligence Briefs

Active Regulatory Actions

—

HQ Country

NO ACTIVE REGULATORY ACTIONSClean compliance footprint across 0 monitored sites · HQ

View regulatory detail

INTELLIGENCE

Showing 3 of 3 briefs on Unexo Life Sciences Private Limited

REGULATORY INTELLIGENCE·Recall

FDA Initiates Class III Recall for Annora Pharma's Pitavastatin Calcium Due to Foreign Tablet Contamination

Annora Pharma Private Limited faces an FDA Class III recall for 770 bottles of Pitavastatin Calcium 2mg tablets, distributed by NorthStar RxLLC, due to foreign 1mg tablets found in 2mg bottles. This event highlights critical quality control deficiencies at Annora Pharma's Hyderabad facility, necessitating immediate supply chain risk assessment for procurement and regulatory teams.

90-Day Activity

Unexo Life Sciences Private LimitedPitavastatin Calcium

MKMeera Krishnan· Senior Regulatory Intelligence Analyst

2026-03-25

REGULATORY INTELLIGENCE·Recall

FDA Class II Recall: Private Label Skin Care Inc. Benzoyl Peroxide Cleanser Contaminated with Benzene

Private Label Skin Care Inc. has initiated a Class II recall for its Benzaderm BPO Cleanser 10% due to elevated benzene levels. This event, impacting products distributed in California and Georgia, underscores critical supply chain vulnerabilities in dermatological product manufacturing. Procurement and regulatory teams must immediately reassess quality control for benzoyl peroxide APIs and private label partnerships to mitigate significant health and compliance risks.

90-Day Activity

Unexo Life Sciences Private LimitedBenzoyl PeroxideHSN 3004.90

RMRohan Mehta· Senior Supply Chain Intelligence Analyst

2025-10-01 Recall

REGULATORY INTELLIGENCE·Recall

Unexo Life Sciences Faces FDA Class II Recall for 6.8 Million ABSORBINE jr. Menthol Patches Over cGMP Deviations

Unexo Life Sciences Private Limited initiated a Class II recall of 6,848,820 ABSORBINE jr. Extra Large BACK PATCH, Menthol 5%, due to cGMP deviations. This event, now terminated, highlights critical quality control risks for procurement and supply chain leaders sourcing from India, demanding rigorous due diligence to mitigate disruption and ensure product integrity in the US market.

90-Day Activity

Unexo Life Sciences Private LimitedABSORBINE jr. Extra Large BACK PATCH, Menthol 5%

PSPriya Subramaniam· Intelligence Analyst

2024-12-04